期刊文献+

HPV-16 E6、E7基因慢病毒真核表达载体的构建及鉴定 被引量:1

Construction and identification of eukaryotic vector of HPV-16 E6,E7 genes
下载PDF
导出
摘要 目的构建人乳头瘤病毒(HPV)E6、E7基因慢病毒真核表达载体。方法以Si Ha宫颈癌细胞总RNA为模板,利用RT-PCR技术扩增出E6、E7目的片段;选用病毒载体p Lenti6/V5 Directional TOPO Cloning Kit系统构建E6、E7基因慢病毒真核表达载体;分别使用构建好的E6、E7载体转染病毒包装细胞,获得含病毒的上清液,并测定上清液中慢病毒的滴度。结果质粒测序所得序列与人乳头瘤病毒E6、E7基因序列完全吻合,载体构建成功;慢病毒滴度测定结果显示E6样品的慢病毒滴度为1.5×108TU/m L,E7样品的慢病毒滴度为2×108TU/m L,该滴度能够满足后续研究所需。结论 HPV-16 E6、E7基因慢病毒真核表达载体构建成功,可以为进一步研究人乳头瘤病毒E6、E7基因致病机理奠定物质基础。 Objective To construct the eukaryotic expression vector for human papillomavirus (HPV) E6 and E7 genes. Methods We amplified the full-length HPV-16 E6 and E7 genes from the total RNA of the SiHa cell line by RT-PCR technique and sub-cloned the gene into pLenti6/V5 vector, which was identified and confirmed by DNA sequencing. The construction of E6 and E7 transfected viruses was used to package cells. Then we harvested viral supematant and determined the titer. Results The plasmid sequencing was completely consistent with E6, E7 gene sequence, which showed that the vector was successfully construc- ted. The titer of E6 was 1.5× 108 TU/mL, and 2× 108 TU/mL of E7, satisfying the requirements of the subsequent researches. Conclusion The successful construction of HPV-16 E6 and E7 gene eukaryotic ex- pression vector could lay the material foundation for furthering study of the pathogenesis of HPV E6 and E7 genes.
出处 《新疆医科大学学报》 CAS 2015年第6期734-738,共5页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区重点实验室开放课题基金(XJDX0208-2012-03) 新疆医科大学科研创新基金(XJC201310)
关键词 宫颈癌 HPV16 E6、E7基因 慢病毒载体 ervical cancer HPV-16 E6, E7 genes Lentivirus vector
  • 相关文献

参考文献17

  • 1Monsonego J. HPV infections and cervical cancer prevention. Priorities and new directions[J]. Gynecol Oncol, 2005,96(3) : 830-839.
  • 2Wiley D, Masongsong E. Human papillomavirusthe burden of infection[J]. Obstet Gynecol Surv, 2006,61 ( 6 Suppl 1) : S3-14.
  • 3Munoz N, Bosch FX, de Sanjosfi S, et al. Epidemiologic classi- fication of human papitlomavirus types associated with cervical cancer[J]. N Engl J Med, 2003,348(6) :518-527.
  • 4拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 5Jones EE, Wells SI.Cervical cancer and human papillomavirus- esinactivation of retinoblastoma and other tumor suppressor pathways[J]. Curr Mol Med, 2006,6 (7) : 795-808.
  • 6Ferenczy A, Franco E. Persistent human papillomavirus infec- tion and cervical neoplasia[ J]. Lancet Oncol, 2002, 3 ( 1 ) :11-16.
  • 7Yamato K, Fen J, Kobuchi H, et al. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA[J]. Cancer Gene' Ther, 2006,13(3) : 234-41.
  • 8DeFilippis RA, Goodwin EC, Wu L, et al. Endogenous human papillomavirus E6 and E7 proteins differentially regulate pro- liferation, senescence, and apoptosis in HeLa cervical carcinoma cells[J]. J Virol. 2003, 77(2):1551-1563.
  • 9Thierry F, Benotmane MA, Demeret C, et al. A genomic ap- proach reveals a novel mitotic pathway in pap illamavirus car- cinogenesis[J].Cancer Res, 2004,64 (3): 895-903.
  • 10孙宝胜,左雅芳,田琦,欧健,张国胜,刘江山,刘士新.宫颈癌腔内治疗下评估靶区和危及器官的剂量与体积[J].中华放射医学与防护杂志,2013(1):66-67. 被引量:3

二级参考文献112

共引文献107

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部